Genworth Financial Inc. Cl A (GNW) Pops 11.1% for December 23

Equities Staff |

One of the S&P 500’s big winners for Wednesday December 23 was Genworth Financial Inc. Cl A (GNW) as the company’s stock climbed 11.1% to $3.86 on volume of 7.16 million shares.

The stock opened at $3.53 and saw an intraday low of $3.52 and an intraday high of $3.86. All told, the day saw a per-share gain of $0.385. The stock’s average daily volume of 8.34 million and 497.46 million shares outstanding. Genworth Financial Inc. Cl A now has a 50-day SMA is $4.64 and 200-day SMA is $6.32, and it has a 52-week high of $9.19 and a 52-week low of $3.46.

Genworth Financial Inc is a financial security company. It provides insurance, wealth management, investment and financial solutions.

Based out of Richmond, VA, Genworth Financial Inc. Cl A has 5,300 employees and, after today’s trading, reached a market cap of $1.92 billion. Its P/S ratio is n/a, P/B ratio is 0.14, and P/FCF ratio is 0.8.

For a complete fundamental analysis analysis of Genworth Financial Inc. Cl A, check out’s Stock Valuation Analysis report for GNW. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.